Ignite Creation Date:
2025-12-24 @ 7:18 PM
Ignite Modification Date:
2025-12-31 @ 3:10 AM
Study NCT ID:
NCT05217303
Status:
COMPLETED
Last Update Posted:
2023-05-31
First Post:
2022-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HL-085 in NRAS-mutated Advanced Melanoma
Sponsor:
Shanghai Kechow Pharma, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-02
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-02-20
Completion Date Type:
ACTUAL
First Submit Date:
2022-01-07
First Submit QC Date:
None
Study First Post Date:
2022-02-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-29
Last Update Post Date:
2023-05-31
Last Update Post Date Type:
ACTUAL